Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

Kits sold directly to consumers to check a variety of health metrics provide little value when it comes to guiding health ...

The Synthetic Human Genome, or Syn HG, a project launched on June 26th, aims to change that. Funded partly by Wellcome, a ...

MIT engineers have developed a new kind of low-cost, easy-to-use sensor that could bring fast and affordable disease testing ...

MIT’s CRISPR sensor detects cancer and HIV for 50 cents and stays effective for two months without refrigeration.

Codix Bio Ltd, a Nigerian manufacturing firm, is set to spearhead the local production of HIV and malaria test kits at its newly established plant outside Lagos, tackling the shortfall resulting from ...

A worker inspects plastic test cassettes for HIV 1/2 at Codix Bio production plant where HIV and Malaria test kits are locally produced, as it aims to fill the gap left by U.S. funding cuts to ...

In response to reductions in US foreign aid, Nigerian pharmaceutical company Codix Bio Ltd is gearing up to produce millions of HIV and malaria rapid diagnostic test kits at a new facility outside ...

Estimates for CRISPR’s 2025 loss per share have widened from $5.06 to $5.54 in the past 60 days. During the same timeframe, loss per share estimates for 2026 have increased from $3.76 to $4.30.

Nigerian manufacturer Codix Bio Ltd plans to make millions of HIV and Malaria test kits at its new plant outside Lagos for the local and regional market to help fill gaps in the wake of cutbacks ...

Nigerian health technology company Codix Bio Ltd has announced plans to begin large-scale local production of HIV and malaria rapid diagnostic test kits in response to anticipated shortfalls ...

Nigerian manufacturer Codix Bio Ltd plans to make millions of HIV and Malaria test kits at its new plant outside Lagos for the local and regional market to help fill gaps in the wake of cutbacks at ...